biology

Patrik Brundin

Patrik Brundin is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Patrik Brundin rather than just read about it. In short: Patrik Brundin (born December 26, 1961, in Malmö, Sweden) is a neuroscientist known for his research on Parkinson's disease (PD) and Huntington's disease. He is currently a Distinguished Scientist and serving as Therapeutic Area Leader for Movement Disorders at F.

Key takeaways

Patrik Brundin belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Patrik Brundin to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Patrik Brundin from memory before moving on to harder problems.

Reference excerpt

Patrik Brundin (born December 26, 1961, in Malmö, Sweden) is a neuroscientist known for his research on Parkinson's disease (PD) and Huntington's disease. He is currently a Distinguished Scientist and serving as Therapeutic Area Leader for Movement Disorders at F. Hoffmann-La Roche, Pharmaceutical Research and Early Development (pRED). Brundin was educated at Lund University from 1980 to 1992, where he became a full professor in 2000. In 2012, he was appointed the Jay Van Andel Endowed Chair in Parkinson's Research at Van Andel Institute, Grand Rapids, Michigan. Before moving to F. Hoffmann-La Roche in 2022, Brundin held multiple roles at the institute such as the Deputy Chief Scientific Officer, the Director of the Center for Neurodegenerative Science and the Parkinson's Disease Center.

Early life and education Already at age 12, Brundin became interested in studying and finding a cure for PD, a passion influenced by his father's, Bertil Brundin, diagnosis in 1974. While born in Sweden, Brundin spent the majority of his early childhood in the UK, before the family's return to Sweden in 1975. In 1978, Brundin was granted a scholarship to United World College (UWC) of the Atlantic, an international boarding school in Wales, UK. At age 17, he started his research with an Extended Essay on PD as part of the International Baccalaureate (IB) program. Upon completion of his IB diploma in 1980, he entered medical school at Lund University in Sweden and embarked on an M.D.-Ph.D. program. He completed his Bachelor of Science in Medicine in 1983, a Ph.D. in 1988 under the supervision of Swedish neuroscientist Anders Björklund, and an M.D. in 1992.

Career In 1994, Brundin started his own independent research group at Lund University, Sweden, and he was promoted to full professor of neuroscience at the Faculty of Medicine in 2000. His team moved to the Wallenberg Neuroscience Center at Lund University in 1996. In 2011, Brundin was awarded a European Research Council grant to study disease mechanisms in PD. In 2012, he moved to the USA and joined the Van Andel Institute, serving both as the Director of the Center for Neurodegenerative Science and the Head of the Laboratory for Translational Parkinson's Disease Research. He later held positions as the Deputy Chief Scientific Officer and the Director of the Parkinson's Disease Center at the same institute until 2022. During this period, he also chaired the scientific committee of the International Linked Clinical Trials initiative. In 2022, he moved to F. Hoffmann-La Roche where he became a Distinguished Scientist where he has the role of Therapeutic Area Leader for Movement Disorders. Brundin is highly cited, with more than four hundred publications on PD and Huntington's Diseases. He contributed to cell transplantation for PD, took part in initial successful clinical trials, and oversaw subsequent methodological refinements. His work expanded to include the molecular mechanisms of these diseases, co-authoring with Nobel laureate Aaron Ciechanover, a 2002 review on the potential role of impaired protein degradation in neurodegenerative disorders. He and collaborators identified the prion-like propagation of alpha-synuclein aggregates between neurons and developed corresponding animal models. This work contributed to the recognition of alpha-synuclein as a potential therapeutic target in PD. In 2021, Brundin was listed on the Clarivate Highly Cited Researchers List. Since 2022, at F. Hoffmann-La Roche, he has maintained his research focus on alpha-synuclein, participating in clinical trials studying this protein. Brundin has also had several other scientific leadership roles. In 2011 he was a founding co-editor-in-chief of the Journal of Parkinson's Disease and he served in that role for over a decade. Starting in 2012, he served for a decade as the inaugural chair of the International Linked Clinical Trials committee, which was instrumental in conducting the largest drug repurposing program in Parkinson's Disease (PD). He has been a member of the World Parkinson Coalition Board of Directors and the MJ Fox Foundation Executive Scientific Advisory Board. He has also chaired a study section at the National Institutes for Neurological Disease and Stroke (NINDS). He is a scientific co-founder of the biotech companies Acousort AB and RYNE Biotechnology, the latter focused on induced pluripotent stem cell (iPSC)-based transplantation therapy for PD.

Awards and recognition 1999: Dr Eric K Fernström Foundation's Prize to Young Swedish Scientists 2001: Catedra Santiago Grisolía Chair Prize, Valencia, Spain 2001: Chair, Gordon Research Conference on CAG Triplet Repeat Disorders 2003: Medal of Honour from the Swedish Parkinson Association 2003: Bernard Sanberg Memorial Award 2004: Elected as member of Academia Europea 2011: Swedbank Scientific Award in the Memory of Amanda and Per Algot Mångberg 2018: Aligning Science Across Parkinson's Planning Advisory Council 2019: Fulton Lecture Award, World Federation of Neurology 2021: Clarivate Highly Cited Researchers List 2022: Honorary Award for Outstanding Contribution, Tom Isaacs Award

References

Further reading Langston, J William; Palfreman, Jon (1995). The Case of the Frozen Addicts. New York: Pantheon Books. ISBN 0-679-42465-2.

Worked examples

Example 1 — a first encounter with Patrik Brundin

Start with the simplest possible case. Write down what Patrik Brundin claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Patrik Brundin before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Patrik Brundin ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Patrik Brundin

In research: Patrik Brundin appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Patrik Brundin in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Patrik Brundin is common in secondary-school and first-year university syllabi. It links to neighbouring topics 1961 births, American medical researchers, American neurologists, so understanding it makes those chapters shorter.
In everyday life: Look for Patrik Brundin outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Patrik Brundin in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Patrik Brundin means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Patrik Brundin out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Patrik Brundin in simple terms?

Why does Patrik Brundin matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Patrik Brundin?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Patrik Brundin.